InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Sullivan Christopher Ryan, Directeur Comptable. Officer active across 1 companies, notably Avalo Therapeutics, Inc.. In total, 2 disclosures have been logged. Total volume traded: €3k. The latest transaction was disclosed on 10 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
€1,328955 shares@ €1.3902100.0% of flow
Common Stock
SEC:0001879785-21-000039·
Ideal exit: 6 Sept 2022 (T+270)
€1,328955 shares@ €1.39020.0004% mcap50.0% of flow
Common Stock
SEC:0001879785-21-000039:0·
Ideal exit: 6 Sept 2022 (T+270)
2 of 2 declarations
About Sullivan Christopher Ryan
Christopher Ryan Sullivan is the Chief Accounting Officer at Avalo Therapeutics, Inc. He oversees accounting operations and ensures financial compliance for the company. His role is crucial for maintaining financial transparency.
